153 related articles for article (PubMed ID: 21498992)
1. [Effective treatment by both anti-androgen therapy and chemotherapy for a patient with advanced salivary duct carcinoma].
Kuroda H; Sakurai T; Yamada M; Uemura N; Ono M; Abe T; Fujii S; Maeda M; Kohda K; Obata M; Ando M; Iyama S; Kato J
Gan To Kagaku Ryoho; 2011 Apr; 38(4):627-30. PubMed ID: 21498992
[TBL] [Abstract][Full Text] [Related]
2. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
[TBL] [Abstract][Full Text] [Related]
3. Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation.
Kawahara A; Harada H; Akiba J; Kage M
Diagn Cytopathol; 2008 Jul; 36(7):485-93. PubMed ID: 18528886
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
5. Salivary duct carcinoma in the mandible: a case report.
Kikuchi Y; Hirota M; Iwai T; Aoki S; Chikumaru H; Kawabe R; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e41-6. PubMed ID: 17321438
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy.
Prat A; Parera M; Reyes V; Peralta S; Cedrés S; Andreu J; Huguet P; del Campo JM
Head Neck; 2008 May; 30(5):680-3. PubMed ID: 17972317
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
Uijen MJM; Lassche G; van Engen-van Grunsven ACH; Tada Y; Verhaegh GW; Schalken JA; Driessen CML; van Herpen CML
Cancer Treat Rev; 2020 Sep; 89():102069. PubMed ID: 32717621
[TBL] [Abstract][Full Text] [Related]
9. Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy.
Soper MS; Iganej S; Thompson LD
Head Neck; 2014 Jan; 36(1):E4-7. PubMed ID: 23720164
[TBL] [Abstract][Full Text] [Related]
10. [A case of effective weekly paclitaxel administration for advanced gastric cancer].
Hasegawa Y; Kuroda F; Doi T; Takemura S; Nakamura H
Gan To Kagaku Ryoho; 2011 Apr; 38(4):655-7. PubMed ID: 21498999
[TBL] [Abstract][Full Text] [Related]
11. [Salivary duct carcinoma of the sublingual gland--a case report].
Sartorius C; Gille F; Bédrossian-Pfingsten J; Kempf HG
Laryngorhinootologie; 2006 Jul; 85(7):517-9. PubMed ID: 16586279
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma.
van Boxtel W; Locati LD; van Engen-van Grunsven ACH; Bergamini C; Jonker MA; Fiets E; Cavalieri S; Tooten S; Bos E; Quattrone P; Verhaegh GW; Schalken JA; Licitra L; van Herpen CML;
Eur J Cancer; 2019 Mar; 110():62-70. PubMed ID: 30771738
[TBL] [Abstract][Full Text] [Related]
13. [A case of metastatic salivary duct carcinoma successfully treated with trastuzumab-based targeted therapy].
Iguchi F; Taniguchi Z; Kusano J; Takahashi Y; Murai N
Nihon Jibiinkoka Gakkai Kaiho; 2014 Aug; 117(8):1108-14. PubMed ID: 25255650
[TBL] [Abstract][Full Text] [Related]
14. Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma.
Jeong ISD; Moyers J; Thung I; Thinn MM
Am J Case Rep; 2020 Jun; 21():e925181. PubMed ID: 32601266
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
Xu B; Dogan S; Haroon Al Rasheed MR; Ghossein R; Katabi N
Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
Nardi V; Sadow PM; Juric D; Zhao D; Cosper AK; Bergethon K; Scialabba VL; Batten JM; Borger DR; Iafrate AJ; Heist RS; Lawrence DP; Flaherty KT; Bendell JC; Deschler D; Li Y; Wirth LJ; Dias-Santagata D
Clin Cancer Res; 2013 Jan; 19(2):480-90. PubMed ID: 23186780
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.
Nagao T; Gaffey TA; Serizawa H; Iwaya K; Watanabe A; Yoshida T; Yamazaki K; Sageshima M; Lewis JE
Am J Clin Pathol; 2004 Aug; 122(2):222-31. PubMed ID: 15323139
[TBL] [Abstract][Full Text] [Related]
18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
19. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
Udager AM; Chiosea SI
Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773
[TBL] [Abstract][Full Text] [Related]
20. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
Kapadia SB; Barnes L
Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
